UA64009C2 - Pharmaceutical composition comprising antifungal agent and method for its production - Google Patents

Pharmaceutical composition comprising antifungal agent and method for its production Download PDF

Info

Publication number
UA64009C2
UA64009C2 UA2001021260A UA2001021260A UA64009C2 UA 64009 C2 UA64009 C2 UA 64009C2 UA 2001021260 A UA2001021260 A UA 2001021260A UA 2001021260 A UA2001021260 A UA 2001021260A UA 64009 C2 UA64009 C2 UA 64009C2
Authority
UA
Ukraine
Prior art keywords
pharmaceutical composition
hydrophilic polymer
coating
oral pharmaceutical
inert core
Prior art date
Application number
UA2001021260A
Other languages
English (en)
Ukrainian (uk)
Original Assignee
Liconsa Liberation Controlada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8304581&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA64009(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liconsa Liberation Controlada filed Critical Liconsa Liberation Controlada
Publication of UA64009C2 publication Critical patent/UA64009C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
UA2001021260A 1998-07-21 1999-07-20 Pharmaceutical composition comprising antifungal agent and method for its production UA64009C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009801539A ES2157731B1 (es) 1998-07-21 1998-07-21 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
PCT/ES1999/000230 WO2000004881A1 (es) 1998-07-21 1999-07-20 Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion

Publications (1)

Publication Number Publication Date
UA64009C2 true UA64009C2 (en) 2004-02-16

Family

ID=8304581

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2001021260A UA64009C2 (en) 1998-07-21 1999-07-20 Pharmaceutical composition comprising antifungal agent and method for its production

Country Status (30)

Country Link
US (1) US6737082B1 (de)
EP (1) EP1103252B1 (de)
JP (1) JP4190732B2 (de)
KR (1) KR100572135B1 (de)
AT (1) ATE234077T1 (de)
AU (1) AU750730B2 (de)
BG (1) BG65187B1 (de)
BR (1) BR9912300A (de)
CA (1) CA2337509C (de)
CZ (1) CZ291938B6 (de)
DE (1) DE69905905T2 (de)
DK (1) DK1103252T3 (de)
EE (1) EE04415B1 (de)
ES (2) ES2157731B1 (de)
HR (1) HRP20010128B1 (de)
HU (1) HU228895B1 (de)
IL (1) IL140910A (de)
ME (1) MEP26708A (de)
MX (1) MXPA01000681A (de)
NO (1) NO320054B1 (de)
NZ (1) NZ509886A (de)
PL (1) PL194740B1 (de)
PT (1) PT1103252E (de)
RS (1) RS50063B (de)
RU (1) RU2209628C2 (de)
SK (1) SK283279B6 (de)
TR (1) TR200100177T2 (de)
UA (1) UA64009C2 (de)
WO (1) WO2000004881A1 (de)
ZA (1) ZA200101293B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1122456C (zh) * 1996-01-31 2003-10-01 南亚拉巴马医学科学基金会 含有天然的还原叶酸盐异构体的食品和维生素制品
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
DZ3227A1 (fr) 1999-12-23 2001-07-05 Pfizer Prod Inc Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
DK1438961T4 (da) * 2003-01-14 2014-11-17 Acino Pharma Ag Bioækvivalent sammensætning af itraconazol dispergeret i en hydrofil polymer
SI1438960T2 (sl) * 2003-01-14 2013-04-30 Cimex Pharma Ag Sestavek itrakonazola, dispergiranega v hidrofilnem polimeru, z izboljšano biorazpoložljivostjo
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
FR2857591B1 (fr) * 2003-07-17 2007-11-02 Ethypharm Sa Particules comprenant un principe actif sous forme de co-precipite
CN1822843B (zh) * 2003-07-17 2010-04-28 泰博特克药品有限公司 制备含有抗病毒药物颗粒的方法
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
US8653083B2 (en) 2005-08-22 2014-02-18 The Johns Hopkins University Hedgehog pathway antagonists to treat disease
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
JP2013521249A (ja) * 2010-03-05 2013-06-10 ビーエーエスエフ ソシエタス・ヨーロピア 融解物で被覆された医薬形態
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
WO2016189481A1 (en) * 2015-05-25 2016-12-01 Sun Pharmaceutical Industries Limited Once daily oral pharmaceutical composition of isotretinoin
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
KR102419769B1 (ko) 2016-08-11 2022-07-13 아다미스 파마슈티칼스 코포레이션 약물 조성물
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
EP3720844A4 (de) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation Arzneimittelzusammensetzungen
WO2019208801A1 (ja) * 2018-04-27 2019-10-31 凸版印刷株式会社 徐放性複合粒子、徐放性複合粒子の製造方法、乾燥粉体及び壁紙
US12150945B2 (en) 2018-07-20 2024-11-26 Lipocine Inc. Liver disease
EP4452232A1 (de) * 2021-12-22 2024-10-30 Palau Pharma, S.L.U. Multipartikuläre albaconazolzusammensetzung

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4916134A (en) * 1987-03-25 1990-04-10 Janssen Pharmacuetica N.V. 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
TW349870B (en) * 1993-09-30 1999-01-11 Janssen Pharmaceutica Nv An antifungal pharmaceutical composition for oral administration and a process for the preparation thereof
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
DK0904060T3 (da) * 1996-05-20 2004-04-13 Janssen Pharmaceutica Nv Antifungale præparater med forbedret biotilgængelighed
ZA974428B (en) * 1996-05-24 1997-11-24 Schering Corp Antifungal composition with enhanced bioavailability.
NZ333514A (en) * 1996-06-28 2000-05-26 Schering Corp Oral pharmaceutical composition comprising a triazole antifungal compound
DE19626924C2 (de) * 1996-07-04 1999-08-19 Epazon B V Gerät zur Bereitstellung eines Atemgases
WO1998042318A1 (en) 1997-03-26 1998-10-01 Janssen Pharmaceutica N.V. Pellets having a core coated with an antifungal and a polymer

Also Published As

Publication number Publication date
ZA200101293B (en) 2001-08-21
HK1037531A1 (en) 2002-02-15
JP2002521323A (ja) 2002-07-16
NO20010289D0 (no) 2001-01-17
KR20010070990A (ko) 2001-07-28
PT1103252E (pt) 2003-07-31
KR100572135B1 (ko) 2006-04-19
YU3901A (sh) 2003-08-29
EE200100041A (et) 2002-06-17
BR9912300A (pt) 2001-04-17
HU228895B1 (en) 2013-06-28
BG105282A (en) 2001-11-30
EE04415B1 (et) 2005-02-15
CZ2001175A3 (en) 2001-05-16
IL140910A0 (en) 2002-02-10
RU2209628C2 (ru) 2003-08-10
ES2194480T3 (es) 2003-11-16
BG65187B1 (bg) 2007-06-29
IL140910A (en) 2004-03-28
US6737082B1 (en) 2004-05-18
CA2337509A1 (en) 2000-02-03
CZ291938B6 (cs) 2003-06-18
SK862001A3 (en) 2001-08-06
DE69905905D1 (de) 2003-04-17
CA2337509C (en) 2005-12-27
NZ509886A (en) 2002-09-27
RS50063B (sr) 2009-01-22
ES2157731A1 (es) 2001-08-16
NO320054B1 (no) 2005-10-17
EP1103252B1 (de) 2003-03-12
AU750730B2 (en) 2002-07-25
HRP20010128B1 (en) 2003-12-31
WO2000004881A1 (es) 2000-02-03
ATE234077T1 (de) 2003-03-15
HRP20010128A2 (en) 2002-12-31
MEP26708A (en) 2010-06-10
TR200100177T2 (tr) 2001-07-23
HUP0103708A3 (en) 2002-07-29
ES2157731B1 (es) 2002-05-01
JP4190732B2 (ja) 2008-12-03
HUP0103708A2 (hu) 2002-02-28
PL194740B1 (pl) 2007-06-29
EP1103252A1 (de) 2001-05-30
PL345625A1 (en) 2002-01-02
NO20010289L (no) 2001-03-07
DK1103252T3 (da) 2003-07-14
MXPA01000681A (es) 2002-04-24
DE69905905T2 (de) 2004-03-04
SK283279B6 (sk) 2003-05-02
AU4782199A (en) 2000-02-14

Similar Documents

Publication Publication Date Title
RU2209628C2 (ru) Пероральная фармацевтическая композиция на основе соединения, имеющего антигрибковую активность, и способ ее получения
KR0151893B1 (ko) 항진균제 및 폴리머로 코팅된 코아를 갖는 비드
CN100531724C (zh) 双相释放药理活性物质或其它物质的薄膜形制剂
CA2307037C (en) Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production
TWI394595B (zh) Enteric granules and methods for their manufacture
HU227971B1 (en) Tramadol multiple unit formulations and process for producing them
JP2003533470A (ja) 経口投薬形態における、毒性コアの非毒性領域中へのカプセル化
AU729038B2 (en) Benzimidazole pharmaceutical composition and process of preparation
JP2813809B2 (ja) 有核顆粒製剤およびその製造法
KR100605235B1 (ko) 판토프라졸 함유 경질 캡슐 제제 및 그 제조방법
HK1037531B (en) Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method